TGFB1 and familial dilated cardiomyopathy: Therefore, there is urgent need to identify novel effective antioxidant therapy in combination with conventional anti-diabetic therapy to specifically target ROS-induced oxidative stress and other pathophysiological pathways including TGF-β1/Smad pathway in DCM.